Espee Therapeutics Llp - Charges

Every charge - open or closed - that lenders have registered against Espee Therapeutics Llp, with the most recent activity at the top.

2016-11-25 Ahmedabad, Gujarat Active LLP
Share
View plans
ET Espee Therapeutics Llp
Open charges
3
1.07 cr
Closed charges
2
10.24 cr
Total
5
11.31 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Icici Bank Limited 2 10.24 cr
2 Hdfc Bank Limited 3 1.07 cr
All charges (5) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
101191230 Hdfc Bank Limited 26 Nov 2025 - - 32.08 Lakh Open
100927643 Hdfc Bank Limited 06 May 2024 - - 20.00 Lakh Open
100818907 Hdfc Bank Limited 16 Nov 2023 - - 55.00 Lakh Open
100710513 Icici Bank Limited 05 Apr 2023 - 02 Sep 2024 2.45 cr Closed
100429089 Icici Bank Limited 15 Jan 2021 13 Mar 2024 04 Sep 2024 7.79 cr Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Espee Therapeutics Llp?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Espee Therapeutics Llp (CIN: AAH-8938). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Espee Therapeutics Llp.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.